Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast Cancer

University of North Carolina, Chapel Hill

University fo Alabama at Birmingham, Birmingham

Vanderbilt University, Nashville

Mayo Clinic, Rochester

University of Chicago, Chicago

Baylor College of Medicine, Houston

Dana-Farber at Faulkner Hospital, Boston

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston